Grant: Discovery Grants Program - Individual
Queen's University
$79,250.00
Analysis of uterine natural killer cell promotion of endometrial angiogenesis
EF 2006-07
Résumé
An unusual subset of immune cells (uNK cells) appears in the uterus in early pregnancy. In mice, these cells secrete signaling molecules (Interferon-gamma and Vascular Endothelial Cell Growth Factor) which bring about structural changes to maternal spiral arteries (SA), the blood vessels nourishing the placenta and fetus. We believe uNK cells guide blood vessel lining cells (endothelium) as new vessels form in implantation sites, directing them towards fetally-derived placental cells. Three Specific Aims will address our hypothesis. AIM 1 will characterize and correlate key molecular and functional properties of mouse SA during gestation days 8-12. Endothelial, vascular smooth muscle and position-defined uNK cells will be studied using laser capture microdissection, RNA isolation and Realtime quantitative RT-PCR. These molecular data will be correlated with functional data collected using our new technique for intravital microscopy of mouse SA. Uterine artery segments will be compared with control, structurally-stable intestinal vessels. AIM 2 will use microscopic and molecular approaches to define interactions between NK cells and migrating endothelial cells in vitro and in vivo. Lymphocyte-endothelial cell interactions and their regulation by other cell types and molecules will be studied in 3D hanging-drop co-cultures of human uterine microvascular endothelium and activated NK cells. Pregnancies in mice over-expressing interleukin 15 or with targeted gene deletions only in lymphocytes will be used to validate the in vitro results. AIM 3 will address when the uNK cell lineage diverges from NK cells in other tissues by comparing gene expression in decidual, splenic and marrow precursors. These studies model important aspects of human endometrial and fetal health and uterine angiogenesis in livestock where endometrial vascularity correlates with litter size. The data will advance our long-term goal of understanding the biology of uNK cells at the whole animal, cellular and molecular levels, and may provide insights into angiogenic roles of immune cells in general tissue healing or pathogenic remodeling.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
3219-2006
Name nom
Croy, Anne
Department département
Anatomy and Cell Biology
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
79250
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
5
Application title
Analysis of uterine natural killer cell promotion of endometrial angiogenesis
Keyword
NA
Application summary
An unusual subset of immune cells (uNK cells) appears in the uterus in early pregnancy. In mice, these cells secrete signaling molecules (Interferon-gamma and Vascular Endothelial Cell Growth Factor) which bring about structural changes to maternal spiral arteries (SA), the blood vessels nourishing the placenta and fetus. We believe uNK cells guide blood vessel lining cells (endothelium) as new vessels form in implantation sites, directing them towards fetally-derived placental cells. Three Specific Aims will address our hypothesis. AIM 1 will characterize and correlate key molecular and functional properties of mouse SA during gestation days 8-12. Endothelial, vascular smooth muscle and position-defined uNK cells will be studied using laser capture microdissection, RNA isolation and Realtime quantitative RT-PCR. These molecular data will be correlated with functional data collected using our new technique for intravital microscopy of mouse SA. Uterine artery segments will be compared with control, structurally-stable intestinal vessels. AIM 2 will use microscopic and molecular approaches to define interactions between NK cells and migrating endothelial cells in vitro and in vivo. Lymphocyte-endothelial cell interactions and their regulation by other cell types and molecules will be studied in 3D hanging-drop co-cultures of human uterine microvascular endothelium and activated NK cells. Pregnancies in mice over-expressing interleukin 15 or with targeted gene deletions only in lymphocytes will be used to validate the in vitro results. AIM 3 will address when the uNK cell lineage diverges from NK cells in other tissues by comparing gene expression in decidual, splenic and marrow precursors. These studies model important aspects of human endometrial and fetal health and uterine angiogenesis in livestock where endometrial vascularity correlates with litter size. The data will advance our long-term goal of understanding the biology of uNK cells at the whole animal, cellular and molecular levels, and may provide insights into angiogenic roles of immune cells in general tissue healing or pathogenic remodeling.